One of the Pharma stocks engaged in manufacturing APIs, intermediates, and formulations has surged by 6.40% after reporting September quarter results in 2024. The company’s revenue increased by 9.85 percent YOY to Rs. 343.8 crore, and net profit increased by 1042.68 percent YOY to Rs. 17.94 crore.  Stock movement After announcing its quarterly results, Shilpa … Continue reading Cancer drug manufacturing stock jumps 7% after profit increases by 1042% YoY in Q2